Linked Life Data

17803434

Source:http://linkedlifedata.com/resource/pubmed/id/17803434

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-9-6
pubmed:abstractText
The aim of this study was to determine the safety, tolerability, and pharmaco-dynamics of a novel prostanoid fluoroprostaglandin (FP)-receptor agonist, tafluprost (AFP-168), in healthy males.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1080-7683
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
359-65
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males.
pubmed:affiliation
Guildford Clinical Pharmacology Ltd., Guildford, Surrey, United Kingdom. asutton@gcpl.co.uk
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Clinical Trial, Phase I